Fungal Biofilms
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Biofilms are a principal form of microbial growth and are critical to development of clinical infection. They are responsible for a broad spectrum of microbial infections in the human host. Many medically important fungi produce biofilms, including Candida [1], Aspergillus [2], Cryptococcus [3], Trichosporon [4], Coccidioides [5], and Pneumocystis [6]. In this review we emphasize common features among fungal biofilms, and point toward genes and pathways that may have conserved roles. Biofilm cell communities are more resistant to antifungal drugs than planktonic cells. Contributing factors include biofilm structural complexity, presence of extracellular matrix (ECM), metabolic heterogeneity intrinsic to biofilms, and biofilm-associated up-regulation of efflux pump genes. The actual fold increase in resistance varies with both the drug and species. Candida albicans and Candida parapsilosis biofilms are relatively resistant to fluconazole, amphotericin B, nystatin, voriconazole, and others. Aspergillus fumigatus biofilms are relatively resistant to itraconazole and, to some extent, to caspofungin. Cryptococcal biofilms are unaffected by fluconazole and voriconazole, and biofilms of Trichosporon asahii display elevated resistance to amphotericin B, caspofungin, voriconazole, and fluconazole. Azole and amphotericin B therapies are ineffective against Pneumocystis carinii biofilms. Biofilm-associated resistance mechanisms have been characterized in C. albicans and A. fumigatus and include drug binding by ECM and production of persister cells [2,7] (see supplementary references for this section in Text S1). Persister cells represent only a fraction of the population, and probably reflect its metabolic heterogeneity. These mechanisms may pertain to other fungi as well.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the single-celled morphology of yeasts also favours adhesion and biofilm formation, which directly influences environmental persistence, competitiveness and thereby improved biocontrol activity (Fanning and Mitchell 2012; Pandin et al. 2017; Rossouw et al. 2018; Verstrepen and Klis 2006).”
From Biocontrol yeasts: mechanisms and applications (2019) · cites this paper as Fanning and Mitchell 2012
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic control of Candida albicans biofilm development
Finkel, J. S., & Mitchell, A. P. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2475 · Cited by 612 · cited 6×
“ALS1 is the most upregulated of the known adherence genes of C. albicans under biofilm conditions. Garcia-Sanchez et al. (2004) [26] highlight that the ALS genes are differentially expressed in biofilms and have autonomous contributions in the biofilm transcriptome. Nett et al. (2009) [25] observed differential expres…”
BackgroundInfluentialSelf-citationAl-Fattani, M. A., & Douglas, L. J. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46569-0 · Cited by 548
Candida albicans Biofilms Produce Antifungal-Tolerant Persister Cells
LaFleur, M. D., Kumamoto, C. A., & Lewis, K. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00684-06 · Cited by 521
Andes, D., Nett, J., Oschel, P., Albrecht, R., Marchillo, K., & Pitula, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.6023-6031.2004 · Cited by 389
García-Sánchez, S., Aubert, S., Iraqui, I., Janbon, G., Ghigo, J.-M., & d'Enfert, C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.2.536-545.2004 · Cited by 353
Adherence and biofilm formation of non-Candida albicans Candida species
Silva, S., Negri, M., Henriques, M., Oliveira, R., Williams, D. W., & Azeredo, J. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.02.003 · Cited by 304
Candida albicans forms biofilms on the vaginal mucosa
Harriott, M. M., Lilly, E. A., Rodriguez, T. E., Fidel, P. L., & Noverr, M. C. (2010) · Microbiology · doi:10.1099/mic.0.039354-0 · Cited by 301
In vivo biofilm composition of Aspergillus fumigatus
Loussert, C., Schmitt, C., Prevost, M.-C., Balloy, V., Fadel, E., Philippe, B., Kauffmann-Lacroix, C., Latgé, J. P., & Beauvais, A. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01409.x · Cited by 269
Martins, M., Uppuluri, P., Thomas, D. P., Cleary, I. A., Henriques, M., Lopez-Ribot, J. L., & Oliveira, R. (2010) · Mycopathologia · doi:10.1007/s11046-009-9264-y · Cited by 250
Di Bonaventura, G., Pompilio, A., Picciani, C., Iezzi, M., D'Antonio, D., & Piccolomini, R. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00556-06 · Cited by 226
Cited by
Items 301–400 of 490
Wu, Y., Chen, J., Chen, L.-C., Chen, L., Huang, Y., & Liao, C. (2025) · Pathogens · doi:10.3390/pathogens14040308 · Cited by 9
Biofilm development in three-dimensional models infected with Trichophyton rubrum
Mendonça, M. B., Cabral, A. K. L. F., Arantes, B. B. A., dos Santos, R. C., Medina‐Alarcón, K. P., dos Santos, K. S., Gualque, M. W. D. L., Fernandes, L. D. S., Belizário, J. A., Fuzinaga, T. Y. T., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01087-25 · Cited by 8
“As a virulence factor, biofilms offer sev eral advantages, including an ideal configuration for nutrient absorption, antifungal protection, and cellular communication, such as quorum sensing, which contributes to infection persistence by regulating efflux pump genes (31, 33, 34).”
Castillo, C., Masi, M. F., Mishko, A., Sheltzer, A., Speer, A., Tran, H., & Vlahovic, T. C. (2021) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2021.06.005 · Cited by 7
Walter, J.-C., Kissmann, A., Gruber, D., Alpízar-Pedraza, D., Martell-Huguet, E. M., Preising, N., Rodríguez, A., Ständker, L., Kleber, C., Knoll, W., et al. (2025) · Biomolecules · doi:10.3390/biom15030322 · Cited by 9
Sengupta, B., Alrubayan, M., Kolla, M., Wang, Y., Mallet, E., Torres, A., Solis, R., Wang, H., & Pradhan, P. (2025) · Information · doi:10.3390/info16040309 · Cited by 12
“Many medically important fungi form biofilms [10–12] (including yeast Candida [13] and mold [10], which are resistant to antifungal drugs).”
Endophytic fungi-bioinspired nanoparticles potential to control infectious disease
Khan, S., Mathur, A., & Khan, F. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2497795 · Cited by 9
“…clinically significant fungi, such as Aspergillus, Candida , Coccidioides , Cryptococcus , Trichosporon , and Pneumocystis , can produce biofilms (Fanning and Mitchell 2012; lagree and Mitchell 2017). the extracellular matrix, the activity of efflux pumps, the presence of persister cells, the…”
Insights into the evolution of Candidalysin and recent developments
Konwar, A., Mathur, K., Pandey, S., Bhorali, K., Thakur, A., & Puria, R. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04414-z · Cited by 7
“Biofilm formation helps the fungus to survive on abiotic surfaces like dentures and catheters making them hard to eliminate, further increasing the chances of infection (Fanning and Mitchell 2012 ).”
Rayón-López, G., Carapia-Minero, N., Medina‐Canales, M. G., García‐Pérez, B. E., Reséndiz-Sánchez, J., Pérez, N. O., Rodríguez-Tovar, A. V., & Ramírez‐Granillo, A. (2022) · Mycopathologia · doi:10.1007/s11046-022-00692-z · Cited by 8
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch130 · Cited by 9
Mishra, S., Rastogi, S. K., Singh, S., Panwar, S. L., Shrivash, M. K., & Misra, K. (2019) · Molecular Biology Reports · doi:10.1007/s11033-019-05014-z · Cited by 7
Formation, Resistance, and Pathogenicity of Fungal Biofilms: Current Trends and Future Challenges
Aguilar-Marcelino, L., Al‐Ani, L. K. T., Soares, F. E. D. F., Moreira, A. L. E., Téllez‐Téllez, M., Castañeda-Ramírez, G. S., Acosta-Urdapilleta, M. D. L., Díaz-Godínez, G., & Pineda-Alegría, J. A. (2021) · Fungal biology · doi:10.1007/978-3-030-60659-6_18 · Cited by 9
From Biology to Drug Development: New Approaches to Combat the Threat of Fungal Biofilms
Pierce, C. G., Srinivasan, A., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2015) · ASM Press eBooks · doi:10.1128/9781555817466.ch19 · Cited by 8
Yogendraiah, K. M., Sadanandan, B., Natraj, L. K., Vijayalakshmi, V., & Shetty, K. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1572694 · Cited by 6
In vitro Arthrographis kalrae biofilm formation: Scanning electron microscopy and cytotoxic analysis
Souza, B. D. D. O., Arcos, J. J. E., Nakamura, C. V., Nagashima, L. A., Sano, A., Ono, M. A., & Itano, E. N. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.11.002 · Cited by 6
Yeast Biofilms in the Context of Human Health and Disease
Raut, J. S., Doke, S. K., & Karuppayil, S. M. (2017) · Springer eBooks · doi:10.1007/978-981-10-2621-8_6 · Cited by 6
Fungal Differentiation: A Model Phenomenon to Screen Antifungal Drugs
Pathan, E. K., Tupe, S. G., & Deshpande, M. V. (2017) · Springer eBooks · doi:10.1007/978-981-10-4768-8_12 · Cited by 7
Villamizar, L., Barrera, G., Marshall, S. D. G., Richena, M., Harland, D. P., & Jackson, T. A. (2020) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2020.1754953 · Cited by 6
Yeast as plant growth promoter and biocontrol agent
Kapoor, D., & Karnwal, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821394-0.00017-2 · Cited by 10
Gaitán, A. C. R., & del Pozo, J. L. (2021) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2021.03.004 · Cited by 9
Rebaza-Cardenas, T. D., Ludeña, Y., Samolski, I., & Villena, G. K. (2020) · Journal of Fungi · doi:10.3390/jof6040376 · Cited by 6
“Some genes expressed in biofilms encode transcription and translation factors, regulators, and those involved in ribosomal protein synthesis and protein turnover, multi-drug resistance transporter genes, enzymes for extracellular matrix synthesis, extracellular enzymes as well as genes for adherence and secondary meta…”
Ndlovu, B., Africa, C. W. J., Klaasen, J. A., & Rahiman, F. (2021) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2021.100474 · Cited by 7
Zhang, H., Xu, C., Hu, C., Xue, Y., Yao, D., Hu, Y., Wu, A., Dai, M., & Ye, H. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-02987-9 · Cited by 6
“In addition to enhancing pathogenicity, biofilms provide strong resistance to antifungal agents and host immune factors, leading to persistent catheter-related fungal infections in clinical practice [48].”
Yang, G., Yang, R., Zhu, X., Xu, Q., Niu, X., Miao, C., Wei, W., Wang, C., Wang, T., & Wu, D. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00222-25 · Cited by 5
“Biofilm, a structured microbial community anchored by a protective matrix, can form from single or mixed cultures of hyphal cells and yeast forms (44).”
Romero, O., & Geddes‐McAlister, J. (2025) · mBio · doi:10.1128/mbio.02303-24 · Cited by 6
“In harsh environments, microorganisms often organize into biofilms, which are aggregations of cells embedded in an extracellular polysaccharide matrix (EPM), rather than individual cells to promote survival (102, 103).”
Mechanisms Of Dermatophyte Resistance To Antifungal Substances
Łagowski, D., Gnat, S., & Nowakiewicz, A. (2020) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2020.59.2.012 · Cited by 7
RetractedPrusty, J. S., Kumar, A., & Kumar, A. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2418125 · Cited by 8
“…antimicrobials, and grow upon the removal of the drug(s). these persisted cells are a major threat because of the trou-bling nature of the biofilms (Fanning and Mitchell 2012). the capacity of C. albicans to switch from yeast to hyphal form is the basis of its pathogenicity and formation of…”
Presence of Biofilms in the Lacrimal Sac Mucosa
KOŞARSOY, M., Özer, S., Öǧretmenoǧlu, O., Tatar, İ., Atay, G., Mocan, M. C., Yücel, T., & Önerci, M. (2013) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2013-34318 · Cited by 5
Magnetic hyperthermia adjunctive therapy for fungi: in vitro studies against Candida albicans
Suneet, K., Sridhar, S., Agiwal, P., Sridhar, M. S., Sanyal, K., & Jain, S. (2019) · International Journal of Hyperthermia · doi:10.1080/02656736.2019.1609705 · Cited by 5
“Further, the chances of failure of the treatment are more after the formation of biofilm cell communities as they are impermeable to antifungal drugs unlike planktonic cells [9].”
BackgroundCombating Biofilm and Quorum Sensing: A New Strategy to Fight Infections
Danquah, C. A., Osei-Djarbeng, S. N., Agana, T. A., Boakye, Y. D., & Adu, F. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89227 · Cited by 7
Biased eviction of variant histone H3 nucleosomes triggers biofilm growth in Candida albicans
Brahma, P., Aggarwal, R., & Sanyal, K. (2023) · mBio · doi:10.1128/mbio.02063-23 · Cited by 5
“Drug resistance in biofilm cells is caused not only due to enclosure within an extracellular matrix but also by rewired metabolic state and elevated expression of genes for drug efflux pumps (9, 10).”
BackgroundThe Significance of Fungal Biofilms in Association with Plants and Soils
Harding, M. W., Marques, L. L. R., Shore, B., & Daniels, G. C. (2017) · Wiley eBooks · doi:10.1002/9781119246329.ch8 · Cited by 6
Aggarwal, P., & Kashyap, B. (2018) · Indian Journal of Medical Specialities · doi:10.1016/j.injms.2018.05.002 · Cited by 5
Complex microbial systems across different levels of description
von Bronk, B., Götz, A., & Opitz, M. (2018) · Physical Biology · doi:10.1088/1478-3975/aac473 · Cited by 7
Obručová, H., Kotásková, I., Tihelková, R., Holá, V., Růžička, F., & Freiberger, T. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01861-18 · Cited by 6
“may be critical for clinical infection development (2).”
BackgroundCarbonic anhydrases from pathogens
Bonardi, A., Gratteri, P., & Nocentini, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816476-1.00019-8 · Cited by 6
Nanoparticles for Biofilm Control
Ranjit, P., Aerupula, M., Shaik, F., & Reddy, K. V. (2021) · Environmental and microbial biotechnology · doi:10.1007/978-981-15-9916-3_9 · Cited by 5
Polymicrobial biofilms: Impact on fungal pathogenesis
Costa-Orlandi, C. B., Bila, N. M., Vaso, C. O., Pires, A. C. M. D. S., Silva, S. D. M., Medina‐Alarcón, K. P., Marcos, C. M., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99977-9.00040-5 · Cited by 9
Current and emerging therapies for fungal biofilms and systemic infections
Elgammal, Y., Martinez, R. I. G., Requejo, A., & Martinez, L. R. (2025) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2025.2570185 · Cited by 4
“…C. albicans, C. neoformans , and A. fumigatus as they make up three of the most common fungal pathogens with well-characterized biofilm structures (Fanning and Mitchell 2012). it highlights the progress on elucidating the efficacy of novel antifungal options, drug repurposing, natural products,…”
Anticancer drugs targeting topoisomerase II for antifungal treatment
Kondaka, K., Rząd, K., Maciejewska, N., & Gabriel, I. (2025) · Scientific Reports · doi:10.1038/s41598-025-93863-z · Cited by 5
“The ability of fungal cells to perform yeast-to-mycelium transformation as well as biofilm formation are important factors for virulence 53,54 .”
Tetz, V., Kardava, K. M., Vecherkovskaya, M. F., Khodadadi‐Jamayran, A., Tsirigos, A., & Tetz, G. V. (2025) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiaf085 · Cited by 5
Carpenter, R. E. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.117005 · Cited by 5
Swebocki, T., Kocot, A. M., Ciemińska, K., Bortolus, C., Muchembled, J., Mechouche, M. S., Jacquin, J., Haddadi, K., Siah, A., Sendid, B., et al. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c01159 · Cited by 4
Xu, H., Gao, Y., Liang, T., Wang, Q., Wan, Z., Li, R., & Liu, W. Y. (2024) · Mycology: An International Journal on Fungal Biology · doi:10.1080/21501203.2023.2299472 · Cited by 4
“Furthermore, additional mechanisms, such as biofilm formation (Fanning et al. 2012) and overexpression of drug efflux pumps (Coleman and Mylonakis 2009), also contribute to triazole resistance.”
BackgroundDiscovery of penicillic acid as a chemical probe against tau aggregation in Alzheimer's disease
Shyong, J., Wang, J., Huynh, Q.-D. T., Fayzullina, M., Yuan, B., Lee, C., Minehan, T. G., Seidler, P. M., & Wang, C. C. C. (2024) · Chemical Science · doi:10.1039/d4sc05469e · Cited by 4
Unravelling fungal pathogenesis: Advances in CRISPR-Cas9 for understanding virulence and adaptation
Nair, A., Rao, A. S., Surabhi, M. A., Gnanika, M., & More, S. S. (2025) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2025.104006 · Cited by 4
Ježíková, Z., Pagáč, T., Víglaš, J., Pfeiferová, B., Šoltýs, K., Bujdáková, H., Černáková, L., & Olejníková, P. (2019) · Current Microbiology · doi:10.1007/s00284-019-01678-9 · Cited by 5
Biofilms: The Good and the Bad
Yadav, S. K., & Sanyal, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-30757-8_2 · Cited by 5
Machado, C. B., da Silva, C. R., Barroso, F. D. D., Campos, R. D. S., Sá, L. G. D. A. V., do Nascimento, F. B. S. A., Cavalcanti, B. C., Júnior, H. V. N., & Neto, J. B. D. A. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101080 · Cited by 4
Evolution of antimicrobial drug resistance in human pathogenic fungi
Mir, M. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96127-1.00009-7 · Cited by 5
Seidlova, V., Pikula, J., Kolařík, M., Nováková, A., Čmoková, A., Ghazaryan, A., Němcová, M., Bednarikova, S., Patra, S., Kokurewicz, T., et al. (2023) · BMC Veterinary Research · doi:10.1186/s12917-023-03603-6 · Cited by 4
Smart nanomaterials and control of biofilms
Chauhan, A. K., Singh, S. P., Yadav, B., Khatri, S., & Husen, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99546-7.00001-x · Cited by 5
Ekdahl, L. I., Salcedo, J. A., Dungan, M. M., Mason, D. V., Myagmarsuren, D., & Murphy, H. A. (2023) · eLife · doi:10.7554/elife.81056 · Cited by 6
“…multicellular phenotypes, only invasive and pseudohyphal growth have been linked to pathogenicity in S. cerevisiae ( McCusker et al., 1994a ; Phadke et al., 2018 ; Palecek et al., 2002 ), although biofilm formation has been linked to pathogenicity in other fungi ( Fanning and Mitchell, 2012 ).”
BackgroundBiçer, M. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03744-0 · Cited by 6
Delattin, N., Brucker, K. D., Craik, D. J., Cheneval, O., Coninck, B. D., Cammue, B. P. A., & Thevissen, K. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03336-14 · Cited by 4
Candida species in periodontal disease: A literature review
Anjana Suresh, U., Nisha, K. J., Shruthi, S., Guru, S., & Batra, P. (2020) · IP International Journal of Periodontology and Implantology · doi:10.18231/j.ijpi.2019.027 · Cited by 4
Hong, S., Kim, S.-K., Chung, C. H., Yun, C., Lee, J., Cho, C.-S., & Huh, W. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01048-24 · Cited by 3
Anticandidal Activity of Lipopeptides Containing an LL-37-Derived Peptide Fragment KR12
Paduszynska, M. A., Neubauer, D., Kamysz, W., & Kamysz, E. (2025) · Molecules · doi:10.3390/molecules30071598 · Cited by 3
“Generally, such significant differences between the activity against planktonic cells as compared to that against biofilm have often been seen for conventional antimicrobials [31,32].”
Synergistic anti-Candida effects of essential oil blends on biofilms at various maturation stages
Balázs, V. L., Puskár, L., Ormai, E., Farkas, Á., Utczás, M., Kocsis, B., Papp, N., Kerekes, E. B., Biró, V., & Kocsis, M. (2026) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2026.107515 · Cited by 3
Vaccaro, A., Cooper, J. F., Rodríguez, A. V., Badali, H., Kean, R., Ramage, G., & Lopez-Ribot, J. L. (2026) · Journal of Fungi · doi:10.3390/jof12040247 · Cited by 4
“Biofilm biogenesis relies on nutrient availability, sensory mechanisms, positive and negative transcriptional regulation, and divergent gene expression profiles that can induce metabolic and adaptive changes optimal for nutrient acquisition and survival [99].”
Lindsay, D., Nowakowsky, K., Harrigan, M., Killington, A., Loh, M. L., & Robertson, R. (2024) · Food Control · doi:10.1016/j.foodcont.2024.110350 · Cited by 3
Trush, M. M., Kovalishyn, V., Ocheretniuk, A. D., Kobzar, O. L., Kachaeva, M. V., Броварец, В. С., & Metelytsia, L. O. (2018) · Current Drug Discovery Technologies · doi:10.2174/1570163815666180418145422 · Cited by 3
High‐Throughput Computational Analysis of Biofilm Formation from Time‐Lapse Microscopy
Salama, O. E., & Gerstein, A. C. (2021) · Current Protocols · doi:10.1002/cpz1.194 · Cited by 4
“…have been reported to be highly resistant to a variety of antifungal drugs including fluconazole, itraconazole, amphotericin B, nystatin, and chlorhexidine (Chandra et al., 2001; Fanning & Mitchell, 2012; Hawser & Douglas, 1995; Kuhn, Chandra, Mukherjee, & Ghannoum, 2002; Sherry et al., 2017).”
BackgroundEvolutionary Epidemiology Consequences of Trait-Dependent Control of Heterogeneous Parasites
Miele, L., Evans, R. M. L., Cunniffe, N. J., Barceló, C. T., & Bevacqua, D. (2023) · The American Naturalist · doi:10.1086/726062 · Cited by 3
“Widespread examples of such mechanisms are metabolic regulators (Chebotar et al. 2021), bio fi lms (Costerton et al. 1999; Fanning and Mitchell 2012), ef fl ux pumps (Martinez et al. 2009), fl agella (Lyu et al. 2021), and capsules (Song et al. 2021).”
BackgroundEgbe, N. E. (2023) · Journal of Current Biomedical Research · doi:10.54117/jcbr.v3i3.3 · Cited by 3
Sardi, J. D. C. O., Braz, J. D., Marcos, C. M., Fusco‐Almeida, A. M., & Mendes‐Giannini, M. J. S. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106537 · Cited by 4
Dalabehera, M., Subudhi, R. N., Boateng, J. S., Choonara, Y. E., Chaudhari, S., Chellappan, D. K., Kanojia, N., Mnqiwu, K., Singh, T. G., & Negi, P. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2556014 · Cited by 3
“C. albicans exhibit morphogenesis (see Figure 1, part A), transitioning from yeast to hyphal forms ( h ) during infection [11], which enhances tissue invasion, immune evasion, and virulence [12–15].”
Candidemia Candida albicans clusters have higher tendency to form biofilms than singleton genotypes
Díaz-García, J., Arendrup, M. C., Cantón, R., García‐Rodríguez, J., Gómez, A., Gómez, E., Orden, B., Parisi, G., Pemán, J., Posteraro, B., et al. (2020) · Medical Mycology · doi:10.1093/mmy/myaa002 · Cited by 3
Discovery and development of novel substituted monohydrazides as potent antifungal agents
Chandrika, N. T., Green, K. D., Spencer, A. C., Tsodikov, O. V., & Garneau‐Tsodikova, S. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00167a · Cited by 2
Taheri, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23818-5.00012-0 · Cited by 2
Mind the fungi: towards a philosophy of fungal cognition
Ostos, E. (2025) · Synthese · doi:10.1007/s11229-025-05063-x · Cited by 3
“In the case of fungi, QS could be involved in communication within the same hypha, within a group of hyphae of the same organism, or among various organisms that share a habitat (Fanning & Mitchell, 2012 ).”
InfluentialUtami, A. N., Tasya, A. N., Nora, R. L. D., & Wibawa, T. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002106 · Cited by 2
“In studies on Fusarium and Candida species, biofilm-forming isolates have been seen to have heightened expression of the CDR1 (Candida Drug Resistance 1) and MDR1 (Multidrug Resistance Protein 1) resistance genes, which is associated with higher MIC values and increased treatment challenges [45].”
Fungi dominate eukaryotic microbial assemblages in hot spring biofilms of East and Southeast Asia
Thirumaran, S., George, C., Kortheerakul, C., Khunthong, N., Bhunjun, C. S., Phukhamsakda, C., Chan, K., Chang, Y., Tan, E. J., Daroch, M., et al. (2025) · Environmental Microbiome · doi:10.1186/s40793-025-00816-0 · Cited by 2
“This may reflect that these groups have been implicated as important in biofilm formation [92, 93].”
Shi, J., Lan, N., Zeng, F., Liu, N., Xue, C., & Yang, B. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1774864 · Cited by 3
Černoša, A., Amigo, J. M., Matroodi, F., & Sandak, A. (2026) · Langmuir · doi:10.1021/acs.langmuir.6c01932 · Cited by 2
Antagonistic yeast: Eco-friendly tool for management plant diseases
Gogoi, A. R., Khiangte, L., Thapa, S., Baral, D., & Subba, A. (2024) · International Journal of Advanced Biochemistry Research · doi:10.33545/26174693.2024.v8.i7k.1632 · Cited by 2
“Most yeasts can endure various adverse environments, including high or low temperatures, low humidity, oxidative stress, a lack of nutrients, and an unfavourable pH (Fredluund et al ., 2002) [33] .”
Yue, H., Xu, X., Peng, B., Wang, X., Zhang, S., Tian, J., Wang, S., Song, M., & Liu, Q. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s467418 · Cited by 2
“18 Although C. auris could develop weak biofilm compared to that formed by C. albicans , its biofilm still exhibited high levels of drug resistance compare with its planktonic cells.”
ResultThammawat, S., Fowsantear, W., Sangdee, K., & Sangdee, A. (2024) · International journal of medicinal mushrooms · doi:10.1615/intjmedmushrooms.2024056351 · Cited by 2
Probiotic Enterococcus faecium CRL 183 Inhibits Candida albicans Biofilm In Vitro
Lordello, V. B., de Annunzio, S. R., da Silva, E. P., Taranto, M. P., Fontana, C. R., & Cavallini, D. C. U. (2024) · Microbiology Research · doi:10.3390/microbiolres15040141 · Cited by 2
Belov, D. V., & Belyaev, S. N. (2023) · Practice of Anticorrosive Protection · doi:10.31615/j.corros.prot.2023.107.1-5 · Cited by 2
Biofilm Formation and its Impact on Antifungal Therapy
Müller, F. C. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0194-x · Cited by 3
Lai, W., Hsu, H., Cheng, C., WANG, S., Li, W.-C., Hsieh, P.-S., Tseng, T.-L., Lin, T., & Shieh, J. (2022) · Journal of Fungi · doi:10.3390/jof8030233 · Cited by 3
“Catheters, dentures, prosthesis (abiotic), and mucosal cell surfaces (biotic) are the most common substrates [81].”
BackgroundYunita, M., Lumbantobing, R. M., & Tahitu, R. (2023) · Folia Medica Indonesiana · doi:10.20473/fmi.v59i3.43989 · Cited by 3
Molecular characterization of microbes in the center of barnacle footprints (part I)Preprint
Zhang, Z. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.12.516243 · Cited by 2
“It is interesting that only E and J have a overlapping genus Aspergillus, which is known for biofilm formation propensity [10].”
BackgroundMechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2023) · Wiley eBooks · doi:10.1002/9781683670438.mcm0134 · Cited by 2
Relapsing Vulvovaginal Candidiasis: Treatment with Oxygen Therapy and Hyaluronic Acid
Palmieri, B., Condemi, L., Bertozzi, E., Garoia, F., & Vadalà, M. (2022) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2022.10129 · Cited by 2
“The main virulence factors include: the morphological transition from yeast to hyphal form [10], the expression of cell surface molecules, such as adhesins, to help the Candida to adhere to epithelial cells [11], directional hyphal growth (thigmotropism) [12], the biofilm formation [13], phenotypic switching, the secr…”
BackgroundIn Vitro, In Vivo, and Ex Vivo Models to Study Mixed Bacterial and Fungal Biofilms
Azevedo, A. S., Allkja, J., Kumar, S., Kumar, A., Brás, S., & Rodrigues, C. F. (2022) · Springer series on biofilms · doi:10.1007/978-3-031-15349-5_3 · Cited by 2
Effectiveness & mechanism of phytoconstituents against Candida biofilm
Jha, M., Agarwal, J., Gautam, P., & Kumar, N. (2024) · Environment Conservation Journal · doi:10.36953/ecj.30601324 · Cited by 1
“Proteins, glucans, nucleic acids, and man-nans combine to form the matrix of this product, offering a variety of benefits such as protection and metabolic flexibility (Fanning et al. , 2012; Mayer et al. , 2013).”
Cholesterol-terminated cationic lipidated oligomers (CLOs) as a new class of antifungals
Mahboob, M. B. H., Subramaniam, S., Tait, J. R., Grace, J. L., Elliott, A. G., Floyd, H. E. E., Zuegg, J., Quinn, J. F., Prestidge, C. A., Landersdorfer, C. B., et al. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02317j · Cited by 1
Fungal Biofilms to Provide Light Cementation to Fine Sand
Tirkes, S., Aydin, D., Beyenal, H., & Akin, I. D. (2025) · Geotechnical Frontiers · doi:10.1061/9780784486009.016 · Cited by 1
Brewing Wonders: Biofilm in Beverages
Mazumder, S., Bhattacharya, D., Lahiri, D., & Nag, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-85205-3_12 · Cited by 1
Ramage, G., Kean, R., Mackay, W. G., Vaccaro, A., Lopez-Ribot, J. L., & Howe, M. H. (2025) · Springer series on biofilms · doi:10.1007/978-3-031-93315-8_7 · Cited by 2
The Changing Face of Candida in Southeast Asia
Espiritu, L. M., Capule, P. R. D., Casulla, L. Y., Yu, P. K., Carascal, M. B., Ombao, D. J. N., Notarte, K. I., Guerrero, J. J. G., & Chaturvedi, V. P. (2025) · Springer eBooks · doi:10.1007/978-981-95-2640-6_6 · Cited by 1
Zhong, L., Li, W., Gao, G., Wang, Y., Wang, C., & Pan, J. (2026) · Journal of Fungi · doi:10.3390/jof12010066 · Cited by 1
Evaluation of the Antimicrobial Activity of Selected Psychotropic Drugs Against Yeast Species
Choudhary, K., Jadhav, V., & Sahay, S. (2025) · Journal of Environmental Microbiology and Toxicology · doi:10.54987/jemat.v13i2.1177 · Cited by 1
Squitieri, D., Massaro, F., Mariotti, M., Cacaci, M., Borocci, S., Porcelli, F., Buonocore, F., Bugli, F., & Sanguinetti, M. (2026) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-026-13929-4 · Cited by 1
“These structural alterations suggest that peptide activity compromises the biofilm physical stability, which is a key determinant of persistence and antimicrobial agents tolerance (Fanning and Mitchell 2012).”
Host Immune Responses to Pathogenic Fungi and Contemporary Therapeutic Strategies
Shallal, A. F., Razaq, C. H., Ahmed, A. S., Ahmed, S. S., Eyüpoğlu, V., & Salman, R. S. (2026) · Journal of Mycology and Truffle · doi:10.65999/mycotruffle.2026.26 · Cited by 1
Pierce, C. G., Srinivasan, A., Uppuluri, P., Ramasubramanian, A. K., & Lopez-Ribot, J. L. (2014) · Springer series on biofilms · doi:10.1007/978-3-642-53833-9_13 · Cited by 1
Esparza-García, F. J., & Guerrero-Barrera, A. L. (2015) · Cited by 1
Anti-yeast activity of extracts and fractions from Uvariodendron calophyllum (Annonaceae)
Menkem, E. Z., Toghueo, R. M. K., Mbouna, C. D. J., Djouonzo, P. T., Ngouana, T. K., Fokou, P. V. T., & Boyom, F. F. (2016) · International Journal of Biological and Chemical Sciences · doi:10.4314/ijbcs.v9i6.1 · Cited by 1
Pilz mag Zucker, aber nicht nur Diabetiker
Teichmann, J. (2018) · Info Diabetologie · doi:10.1007/s15034-018-1277-5 · Cited by 1
Metadata
- Authors
- Fanning, S., & Mitchell, A. P.
- Affiliations
- Duke Medical Center (US)
- Carnegie Mellon University (US)
- Corresponding author
- Mitchell, Aaron P.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-04-05
- Volume
- 8
- Issue
- 4
- Pages
- e1002585
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3320593
- OpenAlex
- W3187158005
- Cited by
- 465
- References
- 30
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 30 · 2023: 46 · 2022: 32 · 2021: 41 · 2020: 43 · 2019: 41 · 2018: 24 · 2017: 36 · 2016: 33 · 2015: 29 · 2014: 24 · 2013: 15 · 2012: 6
- FWCI
- 16.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Andrew W. Mellon Foundation
- Richard King Mellon Foundation
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI067703)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Keywords
- fungal biofilms, biofilm formation, fungal pathogens
- MeSH terms
- Antifungal Agents, Fungi, Species Specificity, Biofilms, Drug Resistance, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.